Department of Bioengineering and Therapeutic Sciences

A study by researchers with the UCSF School of Pharmacy, Department of Clinical Pharmacy finds that the Medicaid program is likely paying far more than necessary for medications and not offering patients the most effective ones available.

In fall 2010, a team of 8 school children won multiple awards in the Wisconsin regional and state FIRST® LEGO® League (FLL®) 2010 Body Forward™ Challenge, an international biomedical engineering competition involving a research project and robot games.

Pharmacogenetics expert Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences, is leading the UCSF arm of a research partnership in which her team will profile 2,000 prescri

Kathy Giacomini, PhD, co-chair, UCSF Department of Bioengineering and Therapeutic Sciences, has been named the recipient of the 2011 Scheele Award by the Swedish Academy of Pharmaceutical Scientists. Giacomini is recognized for her work on the pharmacogenetics of membrane transporters and how...

Drug delivery research led by UCSF’s Tejal Desai, PhD, will now be supported by an exclusive worldwide license agreement between UCSF and Zcube

US$1 billion budget gap, student fee increases likely to continue, Levens Lipton keynote address to CPhA, Nkansah and the Dr. Oz television show, Bero and The Cochrane Collaboration and the World Health Assembly, Roy unveils model of bioartificial kidney; Faculty awards: Huang, Galonić Fujimori,...

The bacteria in the human gut that produce antibiotics are the focus of a US$1 million W. M. Keck Foundation grant being led by Michael Fischbach, PhD, a faculty member in the UCSF School of Pharmacy.

Table of contents


Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

The implantable bioartificial kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.

Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartificial kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years.